Cme Group annual ebitda margin
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cme Group EBITDA Margin Growth & History (CME)
Cme Group's ebitda margin was 66.51% for fiscal 2025.
View full Cme Group company overviewCme Group annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 66.51% | +0.50 pp |
| 2024 | 2024-12-31 | 66.01% | +2.17 pp |
| 2023 | 2023-12-31 | 63.84% | +1.07 pp |
| 2022 | 2022-12-31 | 62.77% | +3.22 pp |
| 2021 | 2021-12-31 | 59.56% | +2.41 pp |
| 2020 | 2020-12-31 | 57.14% | +0.72 pp |
| 2019 | 2019-12-31 | 56.42% | −6.85 pp |
| 2018 | 2018-12-31 | 63.26% | −3.23 pp |
| 2017 | 2017-12-31 | 66.50% | +1.70 pp |
| 2016 | 2016-12-31 | 64.80% | +1.14 pp |
| 2015 | 2015-12-31 | 63.66% | +2.59 pp |
| 2014 | 2014-12-31 | 61.08% | +0.72 pp |
| 2013 | 2013-12-31 | 60.35% | −2.40 pp |
| 2012 | 2012-12-31 | 62.75% | −2.77 pp |
| 2011 | 2011-12-31 | 65.52% | +0.24 pp |
| 2010 | 2010-12-31 | 65.29% | −0.37 pp |
| 2009 | 2009-12-31 | 65.65% | −1.49 pp |
| 2008 | 2008-12-31 | 67.14% | +1.22 pp |
| 2007 | 2007-12-31 | 65.92% | — |
Cme Group quarterly ebitda margin
Q2.08
Q3.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 69.82% | −1.85 pp |
| Q1 2026 | 2026-03-31 | 74.09% | +1.60 pp |
| Q4 2025 | 2025-12-31 | 53.29% | +0.26 pp |
| Q3 2025 | 2025-09-30 | 68.63% | −1.31 pp |
| Q2 2025 | 2025-06-30 | 71.67% | +0.89 pp |
| Q1 2025 | 2025-03-31 | 72.49% | +2.26 pp |
| Q4 2024 | 2024-12-31 | 53.03% | +2.80 pp |
| Q3 2024 | 2024-09-30 | 69.94% | +2.03 pp |
| Q2 2024 | 2024-06-30 | 70.79% | +2.57 pp |
| Q1 2024 | 2024-03-31 | 70.23% | +0.69 pp |
| Q4 2023 | 2023-12-31 | 50.23% | +6.25 pp |
| Q3 2023 | 2023-09-30 | 67.91% | +0.41 pp |
| Q2 2023 | 2023-06-30 | 68.22% | +0.34 pp |
| Q1 2023 | 2023-03-31 | 69.53% | −1.09 pp |
| Q4 2022 | 2022-12-31 | 43.98% | +1.39 pp |
| Q3 2022 | 2022-09-30 | 67.50% | +3.54 pp |
| Q2 2022 | 2022-06-30 | 67.88% | +2.48 pp |
| Q1 2022 | 2022-03-31 | 70.62% | +4.93 pp |
| Q4 2021 | 2021-12-31 | 42.59% | +13.06 pp |
| Q3 2021 | 2021-09-30 | 63.96% | +4.46 pp |
| Q2 2021 | 2021-06-30 | 65.40% | +1.90 pp |
| Q1 2021 | 2021-03-31 | 65.69% | −4.77 pp |
| Q4 2020 | 2020-12-31 | 29.52% | −24.15 pp |
| Q3 2020 | 2020-09-30 | 59.50% | +2.61 pp |
| Q2 2020 | 2020-06-30 | 63.50% | +4.97 pp |
| Q1 2020 | 2020-03-31 | 70.46% | +14.18 pp |
| Q4 2019 | 2019-12-31 | 53.67% | −1.54 pp |
| Q3 2019 | 2019-09-30 | 56.89% | −7.27 pp |
| Q2 2019 | 2019-06-30 | 58.53% | −7.01 pp |
| Q1 2019 | 2019-03-31 | 56.28% | −13.06 pp |
| Q4 2018 | 2018-12-31 | 55.22% | −7.54 pp |
| Q3 2018 | 2018-09-30 | 64.16% | −2.58 pp |
| Q2 2018 | 2018-06-30 | 65.53% | −3.04 pp |
| Q1 2018 | 2018-03-31 | 69.34% | +1.52 pp |
| Q4 2017 | 2017-12-31 | 62.76% | +0.13 pp |
| Q3 2017 | 2017-09-30 | 66.74% | +0.62 pp |
| Q2 2017 | 2017-06-30 | 68.57% | +3.07 pp |
| Q1 2017 | 2017-03-31 | 67.83% | +2.76 pp |
| Q4 2016 | 2016-12-31 | 62.62% | +0.99 pp |
| Q3 2016 | 2016-09-30 | 66.12% | +1.57 pp |
| Q2 2016 | 2016-06-30 | 65.50% | +1.06 pp |
| Q1 2016 | 2016-03-31 | 65.06% | +1.09 pp |
| Q4 2015 | 2015-12-31 | 61.64% | +1.83 pp |
| Q3 2015 | 2015-09-30 | 64.54% | +3.80 pp |
| Q2 2015 | 2015-06-30 | 64.44% | +3.44 pp |
| Q1 2015 | 2015-03-31 | 63.97% | +1.12 pp |
| Q4 2014 | 2014-12-31 | 59.80% | +7.76 pp |
| Q3 2014 | 2014-09-30 | 60.74% | −0.20 pp |
| Q2 2014 | 2014-06-30 | 61.00% | −5.29 pp |
| Q1 2014 | 2014-03-31 | 62.85% | +1.88 pp |
| Q4 2013 | 2013-12-31 | 52.04% | −9.92 pp |
| Q3 2013 | 2013-09-30 | 60.94% | −2.07 pp |
| Q2 2013 | 2013-06-30 | 66.29% | +3.12 pp |
| Q1 2013 | 2013-03-31 | 60.97% | −1.79 pp |
| Q4 2012 | 2012-12-31 | 61.96% | +4.42 pp |
| Q3 2012 | 2012-09-30 | 63.01% | −6.14 pp |
| Q2 2012 | 2012-06-30 | 63.17% | −4.37 pp |
| Q1 2012 | 2012-03-31 | 62.75% | −4.00 pp |
| Q4 2011 | 2011-12-31 | 57.54% | −6.69 pp |
| Q3 2011 | 2011-09-30 | 69.15% | +4.25 pp |
| Q2 2011 | 2011-06-30 | 67.54% | +0.22 pp |
| Q1 2011 | 2011-03-31 | 66.75% | +2.28 pp |
| Q4 2010 | 2010-12-31 | 64.23% | −1.00 pp |
| Q3 2010 | 2010-09-30 | 64.90% | −1.78 pp |
| Q2 2010 | 2010-06-30 | 67.32% | +1.11 pp |
| Q1 2010 | 2010-03-31 | 64.47% | −0.03 pp |
| Q4 2009 | 2009-12-31 | 65.23% | — |
| Q3 2009 | 2009-09-30 | 66.68% | −0.11 pp |
| Q2 2009 | 2009-06-30 | 66.21% | −0.94 pp |
| Q1 2009 | 2009-03-31 | 64.50% | — |
| Q3 2008 | 2008-09-30 | 66.79% | — |
| Q2 2008 | 2008-06-30 | 67.15% | — |
Cme Group ebitda margin trends
Over the last five fiscal years, Cme Group's ebitda margin increased from 57.14% to 66.51%, a change of +9.37 percentage points. The latest reported quarter, Q2 2026, shows 69.82%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cme Group source filings ↗Community posts
CME plans European dairy futures and options through EEX transition
CME Group ($CME) agreed with the European Energy Exchange to transition EEX’s European dairy business, including its butter and skimmed-milk-powder indices, as EEX phases out those products. CME plans to establish its own European dairy ind ...
CME sets an FX open-interest record of 4.41 million contracts
CME Group reported a new foreign-exchange derivatives milestone on 7 September 2026. Reported records FX futures and options open interest reached 4,410,167 contracts on 4 September, exceeding the previous 4,269,622 record from 11 June. Tha ...